Arcturus Therapeutics Announces Appointment of Moncef Slaoui, Ph.D., as Chair Designate
Arcturus Therapeutics Holdings Inc. (the "Company", "Arcturus", Nasdaq: ARCT), a commercial messenger RNA medicines company ...
Arcturus Therapeutics appoints Moncef Slaoui as chair designate
Arcturus Therapeutics (ARCT) announced the appointment of Moncef Slaoui as chair designate. Slaoui has been serving on the company’s board of ...
Business Wire4d
Arcturus Therapeutics Announces Appointment of Moncef Slaoui, Ph.D., as Chair Designate
Dr. Slaoui has been serving on the Company’s Board of Directors since June 2024. “Dr. Moncef Slaoui has a long-proven track record in the pharmaceutical and biotechnology industry, and we are ...
Investing4d
Arcturus Therapeutics names Moncef Slaoui as Chair Designate
SAN DIEGO - Arcturus Therapeutics (NASDAQ:ARCT) Holdings Inc. (NASDAQ: ARCT), a company specializing in mRNA medicines for infectious diseases and rare disorders, has appointed Dr. Moncef Slaoui ...
Investing3d
Arcturus Therapeutics names Moncef Slaoui as Chair Designate
SAN DIEGO - Arcturus Therapeutics (NASDAQ:ARCT) Holdings Inc. (NASDAQ: ARCT), a company specializing in mRNA medicines for infectious diseases and rare disorders, has appointed Dr. Moncef Slaoui as ...
pharmaphorum5d
Ex-GSK chiefs Witty and Slaoui join biotech investors
Meanwhile his former colleague Moncef Slaoui, who also left GSK this year, has joined the European life science investor, Medicxi. Slaoui was formerly chairman of pharmaceutical R&D at GSK, and ...
Le Lézard3d
TE Connectivity named among World's Most Admired Companies by Fortune magazine for the eighth consecutive year
TE Connectivity , a world leader in connectors and sensors, has been named to Fortune's World's Most Admired Companies list ...